Skip to content

Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration

Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16534814
Enrollment
200
Registered
2015-07-02
Start date
2015-05-11
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose regulation Nutritional, Metabolic, Endocrine Prediabetes

Interventions

Participants are randomly allocated to either the telephone only or telephone plus web health coaching service. Participants are asked to fill in questionnaires about their condition and the service t

Sponsors

University of Manchester
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. IGR confirmed by HbA1c between 42-47 mmol/ml in last 6 months 2. Access to a telephone and home internet

Exclusion criteria

Exclusion criteria: 1. They were referred to the face-to-face group IGR education session and do not go onto receive telephone only support 2. They are already diagnosed with type 2 diabetes 3. They have gestational diabetes 4. They are aged less than 18 years old 5. They refuse consent 6. They have no English 7. Their GP considers them incapable of participating (e.g. dementia, learning difficulties, vision or motor skills limitations)

Design outcomes

Primary

MeasureTime frame
Client Satisfaction Questionnaire (self-reported questionnaire) at baseline and at 9-month follow-up

Secondary

MeasureTime frame
Health outcomes: Change in HbA1c, weight (kg), and BMI (from baseline to follow-up at 9 months), Quality of life (self reported EQ-5D), mental health (Mental Health Inventory-5) Health experience and self-management: Summary of Diabetes Self-Care Activities (SDSCA), Patient Activation Measure (PAM) Direct costs of delivery of intervention

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 12, 2026